However, the study also reveals a surprising and critical distinction: not all bodies of water are created equal when it comes to human health. Living within roughly 30 miles of the ocean or gulf was tied to a longer lifespan, but city residents near inland rivers and lakes showed the reverse trend, averaging about 78 years—slightly below the national norm.

The Coastal Advantage: More Than Just a View

The study’s lead researcher, Jianyong “Jamie” Wu, and his team delved into the complex factors that might explain this stark difference. Their analysis points to a mix of environmental and social factors that give coastal areas a significant health advantage.

One of the most significant findings was the difference in climate. Compared to inland locations, coastal areas usually have gentler climates with cooler summers and far fewer days of extreme heat. These cooler summers can reduce the risk of heat-related illnesses and stress on the body. This is a crucial finding, as rising global temperatures have been linked to an increase in mortality, particularly in urban heat islands.

Air quality also tends to be better along the coast, where steady sea breezes scatter pollutants and keep the atmosphere cleaner. This contrasts sharply with many inland cities situated along rivers, which often have higher levels of air pollution from industry, vehicles, and other urban sources.

The study also highlighted the socioeconomic benefits of coastal living. Coastal areas often boast higher incomes and greater opportunities for outdoor recreation, such as walking, cycling, and water sports. These factors contribute to a healthier lifestyle, reducing the risk of conditions like obesity and heart disease.

Earlier studies have connected water proximity with better health, but this research is the first to closely compare how different kinds of “blue spaces” influence life expectancy.

Inland Urban Waters: A Different Story

So why do urban residents living near inland rivers and lakes face a shorter life expectancy? The researchers suggest that pollution, poverty, and a lack of safe recreational opportunities play a key role.

Many of America’s major rivers and lakes have historically been and continue to be industrial and transportation hubs. This has led to higher levels of air and water pollution, which can negatively impact public health.

The study also noted that these urban areas often face higher rates of poverty, which is a well-known determinant of health. Lower-income neighborhoods may have less access to quality healthcare, healthy food options, and safe public spaces for physical activity.

Furthermore, the risk of natural disasters like flooding is a significant factor. Flooding can disrupt communities, damage infrastructure, and expose residents to contaminated water, all of which can have long-term health consequences. Tidal movements follow a predictable rhythm, but floods along rivers can strike suddenly and cause severe damage in nearby communities.

A Call to Re-evaluate Our “Blue Spaces”

The findings of this groundbreaking study challenge the widely held assumption that any proximity to water is beneficial. It forces a re-evaluation of how we view and manage our “blue spaces.” The study’s authors emphasize that health inequities, driven by complex environmental and social factors, are a major reason for the differences they observed.

In recent years, life expectancy in the United States has dropped more sharply—and recovered more slowly—than in other high-income countries. This study provides valuable insight into this trend, suggesting that environmental factors tied to geography and socioeconomic status are playing a key role.

While moving to the coast isn’t a realistic option for everyone, the study offers a powerful message for public health officials and urban planners. It highlights the need to address pollution, improve access to safe recreational spaces, and mitigate environmental risks in all communities, especially those near inland waters.

The key to a longer, healthier life may not be just living by the water, but living in a community where the water—and all the factors that come with it—are clean, safe, and supportive of a healthy lifestyle.

The post Living Near the Ocean May Add Years to Your Life, New Study Finds appeared first on Medical Journal Daily.

This research not only offers a new therapeutic avenue but also sheds light on the shared biological mechanisms that may link autism and epilepsy.

The Study

The study focused on the reticular thalamic nucleus (RT), a part of the brain responsible for processing sensory information. The researchers used mouse models of autism spectrum disorder (ASD), which were genetically modified with mutations in the CNTNAP2 gene, a gene strongly associated with autism.

These mice exhibited classic autism-like behaviors, including repetitive grooming, social withdrawal, hyperactivity, and an increased susceptibility to seizures. The scientists discovered that the neurons in their RT were overactive, a phenomenon linked to strong currents in what are known as T-type calcium channels.

The team then introduced Z944, also known as ulixacaltamide, a drug being studied as a potential treatment for seizure disorders. Z944 is a T-type calcium channel antagonist, meaning it works by blocking these specific currents.

The results were nothing short of remarkable. After administering just one dose of Z944, the mice showed a significant reversal of their autistic behaviors. Their repetitive grooming decreased, they became more socially interactive, and their hyperactivity was reduced.

The drug appeared to “quiet” the overactive RT region, leading to a profound change in their behavior. This finding was further validated when the researchers genetically modified the mice to have increased activity in the RT, causing the autistic behaviors to return.

This suggests that Z944’s ability to suppress this specific brain region is the key to its therapeutic effect.

The Overlap Between Autism and Epilepsy

The findings of this study provide crucial evidence for a long-suspected connection between autism and epilepsy. Autistic individuals are up to 30 times more likely to develop epilepsy than the general population. This high comorbidity has led experts to believe that the two conditions may share underlying biological mechanisms, and this new research strongly supports that theory.

The study suggests that the same overactive neural circuits and channels in the RT that contribute to autistic symptoms may also be a factor in seizure activity. This potential overlap not only explains why the conditions often coexist but also highlights a promising new target for treatment that could address both simultaneously.

While the prospect of a single-dose treatment is exciting, the researchers are quick to emphasize that these findings are still preliminary and based on animal models.

It remains unclear how these results will translate to humans. However, the study provides a critical framework for future research. The scientists note that the next steps should focus on understanding how the RT’s influence on the broader brain circuitry affects the full spectrum of ASD behaviors.

This knowledge could pave the way for highly precise, circuit-specific interventions tailored to the needs of individuals with autism. As Z944 continues its clinical trials for epilepsy, its potential as a dual-purpose drug for both epilepsy and autism remains a captivating possibility that could fundamentally change the lives of millions.

[Source]

The post New Seizure Drug Shows Promise in Reversing Autism Symptoms in Mice appeared first on Medical Journal Daily.

How Light at Night Disrupts the Body

Nelson’s research shows that artificial light at night interferes with the body’s internal clock, suppressing melatonin production and disrupting the natural light–dark cycle that governs many biological functions. This disruption affects multiple systems:

Brain and mood: Exposure to dim light during normal sleep hours has been shown in animal studies to increase brain inflammation, reduce levels of brain-derived neurotrophic factor (BDNF), and cause behaviors linked to depression.

Metabolism: Nighttime light alters circadian gene expression, which can impair insulin sensitivity, promote weight gain, and disturb glucose regulation.

Immune function: Irregular light exposure can suppress normal immune responses or cause chronic low-grade inflammation, increasing vulnerability to illness.

These effects can appear even with relatively low light levels—around 5 lux, similar to the glow from a dim bedside lamp. Research has linked such exposure to a greater risk of metabolic disorders, cardiovascular disease, and mood disorders.

From Laboratory Studies to Clinical Trials

While much of the foundational work comes from controlled lab experiments, Nelson’s team is translating these findings into real-world applications through clinical trials. In hospital intensive care units (ICUs), patients are often exposed to bright artificial light around the clock, which may slow recovery. Nelson’s group is testing interventions such as adjusting light wavelengths and timing to improve outcomes for stroke and cardiac surgery patients.

Another study focuses on night-shift nurses, who are at high risk for sleep problems and mood disturbances. By using blue-light visors at specific times, the research aims to help reset their circadian rhythms, potentially improving cognitive performance and overall well-being. These trials explore whether similar strategies could support shift workers in other industries, where irregular schedules make it hard to maintain natural sleep–wake cycles.

Nelson also points out that the time of day can affect research results. Experiments done in the morning might give different outcomes than those done in the evening, but many studies don’t record or control for this. Keeping track of when tests are done could make biomedical research more consistent and reliable.

Practical Steps for Protecting Circadian Health

Nelson’s work underscores that small lifestyle changes can help protect circadian rhythms and reduce the health risks of artificial light at night. Strategies supported by current evidence include:

Limit blue light exposure after sunset: Use warmer-toned light bulbs in the evening and enable night mode on screens.

Block ambient nighttime light: Blackout curtains or eye masks can reduce intrusion from streetlights and outdoor lighting.

Maintain regular sleep–wake cycles: Going to bed and waking up at consistent times helps reinforce natural rhythms.

Increase daylight exposure: Spending at least 30 minutes outside in the morning boosts alertness and helps anchor the circadian clock.

Nelson’s recent book, Dark Matters, offers a detailed guide for the public on aligning daily habits with biological timing to improve long-term health.

Artificial light at night is now recognized as a growing public health concern, with research linking it to chronic disease risk and mental health challenges. Nelson’s investigations—from molecular changes in the brain to patient care in the ICU—show that circadian disruption is not just a sleep issue but a multi-system health problem. Adopting circadian-friendly lighting practices and reducing nighttime light exposure could play a key role in preventing illness and improving well-being.

[Source]

The post How Light at Night Affects Brain, Mood, and Metabolism appeared first on Medical Journal Daily.

What is Vein of Galen Malformation?

In a person with Vein of Galen malformation (VOGM), arteries connect directly to veins deep in the brain without the normal network of capillaries in between. Without this slowing mechanism, blood rushes at high pressure into the brain’s deep veins, placing strain on the heart and affecting brain function.

The condition can cause a range of serious problems, including heart failure, a build-up of fluid in the brain (hydrocephalus), seizures, developmental delays, and sometimes bleeding within the brain. If left untreated, it carries a very high risk of death—some estimates put mortality at more than three-quarters of cases. Even when treated, the risks remain significant.

Most children diagnosed with VOGM undergo a less invasive treatment known as endovascular embolization. In this procedure, doctors insert a catheter—typically through the groin—and navigate it through the blood vessels until it reaches the abnormal connection in the brain. Special materials are then placed to block the abnormal connections. This technique has transformed survival rates and outcomes for many patients.

A Different Kind of Challenge

For Conor O’Rourke, a three-year-old from Liverpool, standard treatment was not enough. His VOGM was first picked up during a routine check, when a consultant spotted that the shape of his head seemed unusual. Further investigation confirmed the diagnosis—but his case would prove far from straightforward.

But surgeons discovered a major complication—his jugular veins were blocked. This prevented them from reaching the malformation via the normal route, leaving the swelling unchecked and causing damage to his brainstem and spinal cord.

Faced with no viable alternative, neurosurgeon Conor Mallucci and his team at Alder Hey Children’s Hospital designed a new approach. In March, they carried out what is believed to be the world’s first direct open-skull operation for this type of VOGM. By accessing the malformation directly through the skull, they were able to treat it successfully.

Conor’s recovery was described as remarkable. According to his surgical team, he is now “99 per cent cured” and doing well.

Why This Breakthrough Matters

This breakthrough offers hope for children with high-risk cases of Vein of Galen malformation, particularly those whose anatomy or blocked vessels make traditional embolization impossible. By creating an entirely new treatment pathway, it addresses situations where no viable options previously existed and survival chances were low.

Conor’s case also highlights the critical role of early detection—his diagnosis was made possible when an attentive doctor noticed subtle signs during a routine check-up, allowing intervention before further damage occurred.

Finally, it underlines the value of specialist expertise, as Alder Hey is one of only two centers in the UK equipped to carry out such complex pediatric neurosurgery.

Around the world, researchers are also looking at treating VOGM before a baby is born.

In the United States, specialists recently performed the first in-utero embolization, using ultrasound to guide a microcatheter into a fetus’s brain and place small coils to slow blood flow. The baby was delivered with improved heart function and no signs of brain injury. While still experimental, such procedures hint at the possibility of preventing damage before it starts.

The Road Ahead

Even with the best treatment, VOGM is a lifelong condition that requires careful follow-up. Children may need ongoing input from neurosurgeons, cardiologists, neurologists, and developmental specialists to monitor growth and learning.

Historical data from Great Ormond Street Hospital between 2003 and 2008 found that among children who survived treatment, 39% developed normally, 21% had mild developmental delays, and 18% had more significant challenges. These figures show why surgical advances like the one at Alder Hey could make such a difference—not just in saving lives, but in improving how those lives are lived.

[Source: 1,2]

The post World-First Surgery at Alder Hey Saves Toddler from Rare Vein of Galen Malformation appeared first on Medical Journal Daily.

Rewriting Gene Activity in the Diseased Brain

Alzheimer’s disease disrupts how genes operate in brain cells. To understand this better, scientists first mapped the patterns of gene activity in individual neurons and support cells (called glia) from brains affected by the disease. This process, known as gene expression profiling, shows which genes are active or dormant. The researchers then searched for drugs that could flip those patterns back toward normal.

They turned to a large public database called the Connectivity Map, which catalogs how thousands of drugs affect gene activity in human cells. Out of 1,300 drugs, just 10 reversed Alzheimer’s-linked gene patterns across different brain cell types, and only five were already approved by the U.S. Food and Drug Administration.

Using medical records from over 1.4 million patients across California’s university hospitals, the researchers looked for any real-world signs that those drugs might help prevent Alzheimer’s. The records showed that people who had taken some of these medications, mostly for cancer, appeared less likely to develop the disease later on.

Targeting Two Cell Types with a Two-Drug Combo

From this shortlist, the team selected two drugs: letrozole, typically used to treat breast cancer, and irinotecan, used against colon and lung cancers. They believed each drug would target a different cell type — letrozole for neurons and irinotecan for glia — like a two-part key unlocking different doors in the brain.

When given to mice with advanced Alzheimer’s-like symptoms, the drug duo had striking effects. It stopped further damage, reduced toxic protein buildup, and even restored the animals’ ability to remember how to navigate mazes. Memory, in this case, was not just protected, it was brought back from the edge.

The researchers compare the process to rewiring a city after a blackout, where different crews work on separate grid sections, but the lights only come back when efforts are synchronized. Similarly, targeting both neurons and glia may be the missing link that single-drug strategies have overlooked.

A Possible Turning Point for Alzheimer’s Treatment

“This study opens a new door using drugs we already have,” said lead researcher Yadong Huang. His team emphasizes that although results in mice are promising, human trials are essential to confirm safety and effectiveness.

Letrozole and irinotecan, though widely used in cancer treatment, can come with serious side effects. If repurposed for Alzheimer’s, their doses and delivery methods will likely need major adjustments. The upside? Since the drugs are already approved, clinical trials could begin sooner than if researchers had to start from scratch.

With over 55 million people living with Alzheimer’s worldwide and that number set to double in the next two decades.

As co-author Marina Sirota puts it, “When two completely different kinds of data — from cells and from real patients — lead to the same drug, and it works in a model of the disease, we may finally be onto something.”

[Source]

The post Two Cancer Drugs Show Surprising Potential Against Alzheimer’s in Early Tests appeared first on Medical Journal Daily.

A General Immune Boost Instead of a Specific Target

Most cancer immunotherapies rely on identifying and attacking neoepitopes—proteins that arise from mutations specific to a patient’s tumor. This approach works best in cancers with high mutation loads, such as melanoma, but has limited success in tumors with low mutational burden. A study published in Nature Biomedical Engineering and conducted by scientists at the University of Florida challenges that model.

In their experiments, researchers used an experimental mRNA vaccine delivered via lipid nanoparticles, similar to the technology used in COVID-19 vaccines. But instead of encoding a viral protein, this vaccine instructs the immune system to produce proteins that activate an immune response.

One of these proteins, PD-L1, is commonly found on cancer cells and helps them evade immune detection. By artificially inducing PD-L1 expression in tumors, the vaccine made the cancer cells more visible to the immune system, improving the effects of immune checkpoint inhibitors.

Making Resistant Tumors Respond to Treatment

In mouse models of melanoma, the mRNA vaccine cleared drug-resistant tumors and triggered “antigenic spreading”—a process where the immune system begins to recognize and attack multiple tumor-related antigens. In some cases, the vaccine worked even without additional treatments. It was also tested in models of brain, skin, and bone cancers with similarly promising results.

Researchers demonstrated that tumors resistant to checkpoint inhibitors lacked these early immune signals, but became sensitive when treated with RNA-loaded lipid particles that boosted interferon activity. This led to a broader immune reaction, enabling previously unresponsive tumors to respond to immunotherapy.

Together, these results highlight a new paradigm in cancer treatment: instead of customizing a vaccine to match each patient’s unique tumor profile, it may be possible to create a general-purpose vaccine that teaches the immune system to react aggressively to cancer, regardless of the tumor’s specifics.

Laying the Groundwork for an Off-the-Shelf Cancer Vaccine

Dr. Elias Sayour, a pediatric oncologist at the University of Florida and lead investigator on the study, described the results as “a proof of concept” that such a vaccine could eventually become an off-the-shelf solution. Co-author Dr. Duane Mitchell added that this approach may pave the way for more accessible and broadly applicable cancer treatments.

While these findings are based on animal studies, they offer a strong foundation for clinical research. If the vaccine proves effective in humans, it could significantly improve cancer immunotherapy, especially for patients with tumors that previously showed little to no response.

The research not only expands the potential use of mRNA technology beyond infectious disease but also underscores the power of immune system priming. As development continues, a universal cancer vaccine may soon become a powerful tool in the fight against one of the world’s most complex diseases.

[Source]

The post Universal Cancer Vaccine Shows Promise in Boosting Immunotherapy Response appeared first on Medical Journal Daily.

Protein has shifted from basic necessity to cultural symbol. From influencer reels to packaged snack labels, protein is marketed as a fast track to building muscle, shedding weight, and living longer. But the actual science behind how much protein a person needs each day paints a far less dramatic picture.

The Numbers We Miss: How Much Protein Is Really Enough

Most adults need around 0.8 grams of protein for every kilogram they weigh, which comes out to about 56 grams daily for a person who weighs 70 kilograms, or 154 pounds. That number is not a minimum to survive but a generous estimate intended to meet the needs of almost all healthy people. And yet, national data show that most U.S. adults are consuming at least 20% more than that—often without realizing it.

In food terms, hitting the recommended amount is relatively easy. A single serving of meat, a couple of dairy products, and some legumes or whole grains in a day often covers it. Many vegetables, grains, and even bread contribute small but steady amounts. Unless someone is deliberately cutting out protein-rich food groups, actual deficiency is rare.

More protein doesn’t necessarily mean more benefits. While athletes and bodybuilders may need slightly more than the general population, even those groups tend to overshoot the evidence-backed upper ranges. The body doesn’t store protein the way it stores carbohydrates or fat. Once it uses what it needs for tissue repair and other functions, the rest is broken down—leaving the kidneys to clear the leftover nitrogen.

For healthy individuals, this isn’t immediately dangerous, but over time, consistently high intakes may place added strain on the kidneys. There’s also the matter of extra calories: many high-protein foods also come with added fat, sugars, or processing, which can cancel out their supposed health edge. And from an environmental standpoint, excess animal protein adds unnecessary pressure to global food systems.

Animal or Plant? Why Source Quality Still Counts

Protein from meat, dairy, and eggs tends to be classified as “complete,” meaning it contains all the essential amino acids in ideal proportions. But that doesn’t make plant protein inferior. Foods like beans, lentils, nuts, and grains, when eaten in combination, provide the full spectrum of amino acids over the course of a day.

Some people worry that plant-based diets may fall short on protein, but that’s only true with very limited food choices. In fact, experts note that plant proteins often come with added benefits—such as fiber and healthier fats—without the saturated fat and cholesterol found in many animal products.

So if the science is settled, why does the protein craze continue? Experts suggest it’s partly a result of marketing, partly cultural. Protein has never been demonized the way fat and carbs have, making it an easy “safe bet” for brands and influencers alike. There’s also a long-standing association between meat and strength, especially in American pop culture.

But fads tend to ignore context. A high-protein dessert may be framed as healthy, even if it still delivers just as many calories and sugars as its traditional counterpart. And many people view diet through aesthetics: muscle tone is visible, while gut health or metabolic balance is not. This makes protein an appealing but incomplete stand-in for overall well-being.

Simple Nutrition Still Works

In the end, meeting your protein needs doesn’t require powders, hacks, or dessert makeovers. Moderation and variety remain the core of nutritional health. A balanced diet, with enough calories and a mix of protein sources, is more than enough for most people—without the need for protein-laced cookies or steak-for-breakfast routines.

The current obsession with protein reflects more about cultural anxiety than nutritional science. As one nutrition expert put it, every culture has figured out how to meet protein needs without turning food into a supplement aisle. The same still holds true today.

[Source: 1,2]

The post How Much Is Too Much? The Science and Myth of Daily Protein Needs appeared first on Medical Journal Daily.

Rinri Therapeutics, a biotech company born from years of academic research at the University of Sheffield, has been granted approval to begin the world’s first human trial of a cell therapy designed to restore hearing by repairing the auditory nerve itself. Called Rincell-1, the treatment aims to regenerate nerve cells in the inner ear that are essential for transmitting sound signals to the brain—cells that no current treatment can replace.

A New Approach to Hearing Loss

Most people are familiar with hearing loss that comes from damaged hair cells in the inner ear. But in neural hearing loss—seen in conditions like age-related hearing decline (presbycusis) and auditory neuropathy spectrum disorder (ANSD)—the issue lies deeper, in the nerve fibers that connect the ear to the brain. Cochlear implants can help, but only if the auditory nerve is still functional.

Rincell-1 offers something radically new. It uses lab-grown precursor cells—called otic neural progenitor cells—that are designed to mature into working auditory neurons after being delivered directly into the cochlea during cochlear implant surgery. In essence, it’s like rewiring a frayed cable at its core, not just boosting the signal.

“Instead of just amplifying or rerouting sound, we’re aiming to rebuild the broken connection,” said Professor Marcelo Rivolta, the therapy’s lead scientist and co-founder of Rinri Therapeutics.

Trial Details: Who’s In and What’s Next

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved a Phase I/IIa trial, which will be conducted at three of the country’s top hearing research centers. The trial will involve 20 adult participants: ten diagnosed with auditory neuropathy spectrum disorder (ANSD) and ten with advanced age-related hearing loss. In each group, half will receive both a cochlear implant and the experimental treatment, Rincell-1, while the rest will be fitted with the implant only.

This isn’t just about seeing whether the treatment works—it’s first about safety. But researchers will also be looking for early signs that the therapy helps regenerate nerve activity. They’ll use real-time data from a monitoring system built into the cochlear implants, as well as speech perception tests and patient feedback.

Within a year of starting, the team expects to gather proof-of-concept data—an early indicator of whether this therapy could become a viable treatment.

Opening a Door Previously Sealed Shut

The auditory nerve endings are buried deep within the skull, protected by bone and difficult to reach. Traditional surgery would require extensive drilling—something too risky and painful for a routine procedure.

Now, thanks to collaborative research across universities in the UK, Canada, and Sweden, a less invasive method has been developed. Described in Nature Scientific Reports, the new approach uses a natural membrane in the inner ear called the round window as a gateway. Through this access point, surgeons can deliver the regenerative cells directly to the site of damage with far less trauma.

“It’s like slipping a message through a mail slot instead of breaking down the front door,” said Professor Doug Hartley, Rinri’s Chief Medical Officer and one of the architects of the new procedure.

Why This Trial Matters

Neural hearing loss impacts more than 100 million people globally, and that number is projected to grow as populations age. Yet treatments have lagged behind, partly because regenerating nerve tissue in the ear was once considered impossible. Rincell-1 is the first attempt to not just manage symptoms but actually change the trajectory of the disease.

The therapy was developed using Rinri’s OSPREY™ platform—a method for producing ready-to-use cell therapies that don’t rely on patient-specific donor cells. That means, if successful, Rincell-1 could one day be available “off-the-shelf,” making it more accessible and affordable than personalized regenerative therapies.

For now, all eyes are on this first trial. It’s the scientific equivalent of planting a seed in long-frozen soil—no guarantees, but a real chance that something once thought lost could grow again.

[Source: 1,2]

The post First Human Trial of Regenerative Cell Therapy Targets Age-Related and Neural Hearing Loss appeared first on Medical Journal Daily.

Published in the medical journal JAMA, the study tracked participants from age 10 to 14. Although the overall amount of screen time didn’t reliably predict future suicidal behavior, the study found a much stronger link with compulsive digital habits. Children who struggled to disengage, became upset when unable to use their devices, or showed patterns of compulsive use were two to three times more likely to experience suicidal thoughts or make an attempt.

Lead researcher Dr. Yunyu Xiao emphasized that addictive behavior is a better predictor of risk than time spent on devices. “This is the first study to identify that addictive use is important, and is actually the root cause, instead of time,” she noted.

What Addictive Use Looks Like in Children

Addiction in this context doesn’t mean a child simply enjoys using their phone or video games. It refers to an emotional reliance where the child feels unable to stop, increasingly needs more time online to feel satisfied, or uses the device to escape emotional discomfort.

In the study, nearly half of the children displayed high levels of addictive behavior with mobile phones. About a quarter began with low signs of compulsive use, but their dependence grew rapidly over four years. By age 14, those in the “high or increasing use” groups were significantly more likely to report suicide-related behaviors.

Dr. Xiao explained that these behaviors are particularly difficult to manage in adolescents because their prefrontal cortex—the part of the brain responsible for impulse control—is still developing. This developmental stage may explain why some children struggle to disengage from apps or games, even when they are not spending excessive hours online.

How Parents and Policymakers Can Rethink the Problem

Traditionally, advice to parents has centered on limiting screen time with timers, parental control apps, or blanket restrictions. But the study’s findings suggest that focusing solely on the clock may miss children who are emotionally dependent on digital tools. Some children with moderate screen time showed high levels of psychological distress, while others with more hours logged did not.

Mental health experts are calling for a broader approach that includes behavioral assessments and therapy when needed. Cognitive behavioral therapy, in particular, has shown promise in addressing the compulsive patterns associated with addictive digital use.

The findings also raise questions about the role of technology companies. Dr. Mitch Prinstein of the American Psychological Association has urged lawmakers to push for “age-appropriate design” in digital platforms, a model already implemented in the United Kingdom. These design principles could limit persuasive features such as endless scrolling, autoplay, or algorithmic targeting, which are especially difficult for children to resist.

Parents are advised to pay attention not just to how long their children spend on screens, but to how they behave around them. Signs to watch for include frequent interruptions to check devices, visible distress when disconnected, or digital use crowding out sleep, school responsibilities, or time with others.

[Source: 1,2]

The post Study Finds Addictive Behavior Not Screen Time Alone Linked to Youth Suicide Risk appeared first on Medical Journal Daily.

For example, Greenwood observed in 1969 that rural Nigerians with frequent malaria had almost no rheumatoid arthritis, and Gerrard in 1976 found far less allergy among isolated Northern Canadian natives than in urban populations.

These observations suggested that some microbial exposures might protect against immune disorders.

In 1989, Strachan published a landmark study revealing that children from larger families were significantly less likely to develop hay fever. He proposed that in households with multiple older siblings, frequent exposure to everyday infections might help the developing immune system learn to respond more appropriately to harmless triggers.

This idea – the “hygiene hypothesis” – posited that modern sanitation and fewer childhood infections might explain rising allergies and asthma.

Evidence from childhood exposure

Since Strachan’s report, many studies have linked more childhood microbial exposure to lower allergy risk.

Common findings include:

• More older siblings: Each extra older brother or sister (and attendant colds/germs) is associated with lower hay fever and asthma risk.
• Attending daycare early: Children in group care get more infections but develop fewer allergies and asthma.
• Household pets: Kids who grow up with dogs or cats have lower rates of asthma and eczema.
• Growing up on farms: A classic study found European farm children (with rich exposure to soil bacteria and livestock) had much less asthma and hay fever than city kids.
• Common childhood infections: Ironically, infections like measles or stomach bug, and even bacteria such as Helicobacter pylori, tend to be less common in allergic children.

Together these findings suggest that a broad early exposure to microbes – not just “dirtiness,” but normal infections and environmental organisms – helps the immune system learn to distinguish friend from foe.

How It Works: T-Cells, Balance, and the Gut

Immunologists quickly searched for a mechanism. In 1986, just before Strachan’s paper, researchers described two major T‑helper cell types.

Th2 cells drive allergic reactions, while Th1 cells fight viruses and bacteria. This led to a simple model: early-life infections promote Th1 immunity (via interferon) which suppresses Th2-driven allergies.

The prevailing theory at the time suggested that microbial exposure during childhood encouraged the immune system to develop a healthy balance between its different pathways. Without enough stimulation from infections, the Th1 response would remain underdeveloped, allowing the allergy-related Th2 pathway to dominate.

However, the reality proved more complex. Many other immune players are now known: regulatory T cells (Tregs) that calm immune responses, Th17 cells, and innate signals (like IL-25, IL-33) also influence allergy and autoimmunity.

For example, parasitic worms (helminths) trigger Th2 but at the same time boost immune regulators that dampen allergy. We now think of an elaborate network, where a healthy microbial environment helps develop immune tolerance via both innate and adaptive cells.

The “Old Friends” and “Microflora” Theories

Two major offshoots of the hygiene idea highlight specific microbes:

Old Friends Hypothesis (Helminths)

Graham Rook and colleagues proposed that humans co-evolved with certain harmless microorganisms – especially gut worms and other organisms from the natural environment – that are needed to regulate our immune system.

Experiments in mice show that infecting them with particular helminths or even giving helminth-derived proteins can reduce asthma and inflammatory bowel disease symptoms. This suggests these “old friends” stimulate regulatory pathways (like IL-10 and Tregs) that keep both Th1 and Th2 inflammation in check.

Clinical trials are even testing whether controlled exposure to benign worms might treat autoimmune conditions.

Microflora Hypothesis (Gut Bacteria)

Another modern take focuses on the gut microbiome. The idea is that modern habits (antibiotics, C-section births, sterile diets) disturb the normal bacteria in our intestines, tipping the immune system toward hypersensitivity.

Mice raised in germ-free (sterile) conditions have tiny immune tissues and are much more susceptible to infections and allergies. Likewise, certain gut bacteria produce short-chain fatty acids from fiber and stimulate Tregs, fostering gut health and immune balance.

Several human studies back this gut-microbiome view. For instance, infants who later develop asthma often show reduced gut bacterial diversity in the first months of life.

Antibiotic treatment in the first two years is tied to higher asthma risk at school age (in a dose-dependent way). Babies born by C-section (missing exposure to their mother’s vaginal microbes) have altered gut colonization and weaker early Th1 responses.

In contrast, breastfed infants (with human milk oligosaccharides that feed beneficial gut bacteria) tend to have lower allergy rates.

Not every study is uniform – some cohorts find only weak links – but the weight of evidence suggests modern lifestyles that deplete gut microbes can predispose children to overactive immune reactions.

Health Effects: When Microbes Help or Harm

The hygiene hypothesis specifically arose to explain atopic diseases (allergies, asthma, eczema), which have skyrocketed over recent decades in rich countries.

Under normal hygiene conditions, the immune system learns to tolerate harmless proteins (pollen, foods, dust mites) and prevents asthma or allergies. But without early microbial “training,” the immune system may misfire against these things.

Indeed, children with high microbiome exposure (pets, siblings, farms) show lower rates of peanut allergy, hay fever, and asthma. The same patterns hold for many autoimmune diseases. Type 1 diabetes (where the immune system attacks pancreatic cells) is more common in developed nations than in countries with high infectious disease burdens.

Large studies find each older sibling protects – for example, research showed children with household dogs or many siblings were less likely to develop type 1 diabetes.

Breastfeeding also appears protective for diabetes, and, conversely, kids born by C-section (with altered gut flora) have slightly higher diabetes risk.

Inflammatory bowel diseases (Crohn’s, ulcerative colitis) follow similar trends – Western diet and low microbial diversity are risk factors – and germ-free or antibiotic-treated mice are more prone to gut inflammation, underscoring the role of intestinal microbes. (Research is ongoing to definitively pin down these links.)

Some scientists have even begun to wonder if “dirt-deprivation” affects the brain. There is a growing body of work on the gut–brain axis: gut microbes interact with the immune system and nervous system through metabolites and inflammation.

It’s too early to draw conclusions, but advocates of the hygiene hypothesis note that proper microbial exposures may support not just a calm immune system but also mental resilience (an idea sometimes called “old friends” and stress resilience). For example, exposure to nature and pets in early life has been linked in some studies to lower rates of later anxiety or autism, though critics urge caution with these interpretations.

On the other hand, we must remember that many microbial exposures are undeniably harmful. Vaccines and antibiotics have saved millions of lives. Robust hygiene practices in hospitals and food preparation prevent deadly infections.

The goal is balance. A modern take on the hygiene idea is “targeted hygiene”: kill or avoid dangerous pathogens (cholera, tuberculosis, novel viruses) while not sterilizing ourselves of all microbes.
For instance, handwashing after the bathroom or before cooking is crucial, but it’s fine – even good – for family members to share some normal germs during play.

Criticisms and Alternative Views

The hygiene hypothesis has its skeptics. Some argue the term itself is misleading – the evidence doesn’t point to household cleanliness per se, but to broader lifestyle changes. A consensus statement in 2016 flatly noted “the term ‘hygiene hypothesis’ is a misleading misnomer.

There is no good evidence that hygiene, as the public understands, is responsible for these changes”.
In other words, it’s not about letting kids eat dirt; it’s about contact with harmless microbes. Critics also say the theory is oversimplified: many factors (diet, pollution, vitamin D, microbiome changes from food) influence immune development beyond just “dirt or no dirt.”

Some specific criticisms include:

Vaccines vs. allergies: By the logic of hygiene, reducing childhood infections (by vaccinating) might increase allergies. Early studies worried about this, but large birth-cohort research has found no evidence that standard immunizations raise asthma or eczema risk. In fact, after controlling for doctor-visit frequency the apparent link vanished. Thus, vaccines do not appear to fuel the allergy epidemic.

Confounding factors: Families with many siblings or farm exposures differ in many ways (diet, pets, rural lifestyle). It’s possible these correlated factors (not pure “germs”) explain the benefits. Some critics note that family size studies could reflect childhood infections or socioeconomic differences.
Similarly, pet exposures might just mean more outdoor time. Ongoing studies (including ones that measure specific microbial markers) aim to untangle these effects.

Alternative or refined ideas have emerged:

Microbiome Perspective: Many experts now frame it in terms of biodiversity. The “biodiversity hypothesis” suggests that contact with a wide variety of harmless environmental microbes – in soil, plants and animals – is key to immune tolerance. This goes beyond just siblings or worms to include exposure to green spaces, fresh air, and rural soils.

Targeted Hygiene: Practitioners promote a “risk–benefit” approach to cleanliness. Surfaces and hands critical to stopping transmission of dangerous pathogens should be cleaned, while allowing benign microbes to spread in the household environment.

Despite criticisms, the core insight stands: modern life has dramatically changed our microbial exposures, and these changes coincide with the rise of allergies and immune disease.
The hygiene hypothesis has evolved into a more nuanced “microbial theory of health” rather than a call to throw out soap and water.

Practical Takeaways

For now, researchers suggest a balanced approach: encouraging healthy microbial contact without eschewing all hygiene. For example, letting babies crawl on grass, having a pet dog in the house, sharing family meals, and not overusing antibiotics can help diversify a child’s microbiome.

Breastfeeding (which transfers beneficial microbes and sugars) is beneficial, and vaginal birth when possible gives newborns a good microbial start.

At the same time, parents should still use soap and vaccines to prevent serious infections. Public health experts emphasize “targeted hygiene”: sanitize what must be sanitary (to avoid real pathogens), but otherwise don’t worry about everyday germs.

In short, build a rich microbiome through diet, nature and social contact, while maintaining sensible cleaning of known hazards.

In summary, the hygiene hypothesis teaches that “too clean” an environment in early life may deprive the immune system of needed lessons.

A growing body of studies – from sibling surveys to germ-free animal experiments – supports the idea that certain microbial exposures are good for our immune training.

Yet it’s equally clear that maintaining basic hygiene to block dangerous germs remains essential. The goal is not to abandon hygiene, but to redefine it: emphasize infection control where needed, and embrace the invisible helpers (microbes) that keep our immune systems well‑tuned.

[Source]

The post Is Being Too Clean Hurting Our Health? The Hygiene Hypothesis Revisited appeared first on Medical Journal Daily.